Inflammation in atherosclerosis: new opportunities for drug discovery
1AtheroGenics, Inc., 8995 Westside Parkway, Alpharetta, Georgia 30004, USA. cmeng@atherogenics.com
Mini Reviews in Medicinal Chemistry
|January 11, 2005
Abstract:
Many lines of evidence indicate that inflammation is the ultimate cause of atherosclerosis; high cholesterol levels cause atherosclerosis through mechanism of inflammation. Drugs designed to address inflammatory aspects of atherosclerosis will likely be more effective than current therapies in treating and preventing coronary artery disease.
Insights
Inflammation drives atherosclerosis, including that caused by high cholesterol. Targeting inflammation may offer better treatments for coronary artery disease than current options.
Area of Science:
- Cardiovascular Science
- Immunology
- Medical Research
Background:
- Atherosclerosis is a significant contributor to coronary artery disease.
- High cholesterol levels are a known risk factor for atherosclerosis.
- The role of inflammation in atherosclerosis pathogenesis is increasingly recognized.
Purpose of the Study:
- To elucidate the causal role of inflammation in atherosclerosis.
- To evaluate the potential of anti-inflammatory therapies for coronary artery disease.
Main Methods:
- Review of existing evidence linking inflammation and atherosclerosis.
- Analysis of mechanisms by which high cholesterol promotes inflammation.
- Comparative assessment of proposed anti-inflammatory strategies versus current therapies.
Main Results:
- Inflammation is identified as the fundamental cause of atherosclerosis.
- High cholesterol contributes to atherosclerosis specifically through inflammatory pathways.
- Current therapies may be less effective than inflammation-targeted approaches.
Conclusions:
- Inflammation is the pivotal mechanism in atherosclerosis development.
- Targeting inflammatory pathways holds promise for improved prevention and treatment of coronary artery disease.
- Future therapeutic strategies should focus on the inflammatory underpinnings of atherosclerosis.
Related Concept Videos
01:38Inflammation
Overview
01:29Pharmacogenomics: Identification of New Drug Targets
Advances in genomics have profoundly influenced drug discovery by increasing both the speed and accuracy of pharmaceutical development. Pharmacogenomics, which examines how genetic variation influences drug response, facilitates the identification of novel therapeutic targets and enables patient stratification for personalized treatment. These strategies contribute to improved drug efficacy, minimized adverse effects, and more efficient clinical trial design.Mapping genetic differences...
01:30Coronary Artery Disease I: Introduction
Coronary Artery Disease (CAD): An Overview with Scientific InsightsCoronary Artery Disease (CAD), often referred to as C-A-D, is a prevalent blood vessel disorder classified under the broader category of atherosclerosis. Atherosclerosis is a pathological process characterized by the hardening and narrowing of arteries due to the accumulation of atherosclerotic plaques. These plaques are composed of cholesterol, fatty substances, inflammatory cells, calcium, and fibrin, reducing blood flow to...
01:26Coronary Artery Disease II: Pathophysiology
Coronary Artery Disease (CAD) originates from a series of events that impair the function of coronary arteries, the blood vessels responsible for delivering oxygen-rich blood to the heart muscle. The pathophysiology of CAD is closely linked to atherosclerosis, a chronic inflammatory and lipid-driven condition affecting the vascular endothelium.1. Endothelial DamageThe process begins with damage to the vascular endothelium, which serves as a protective barrier between the blood and the vessel...
01:30Atherosclerosis I: Introduction
Atherosclerosis is a progressive disorder characterized by the buildup of plaques on the arterial inner wall, causing them to narrow and harden over time. These plaques comprise lipids, calcium, blood components, carbohydrates, and fibrous tissue. The process primarily affects the intima of large and medium-sized arteries, reducing blood flow in any artery.Etiology and risk factorsThe cause of atherosclerosis is multifactorial, involving a complex interplay among endothelial injury, lipid...
01:27Atherosclerosis II: Clinical Manifestations and Diagnostic Tests
Atherosclerosis is a progressive disorder that leads to the thickening and narrowing of arterial walls due to plaque buildup. This condition can cause various symptoms depending on the arteries affected:Coronary Artery Disease (CAD): This condition affects the coronary arteries and may lead to chest pain (angina), shortness of breath (dyspnea), heart attacks, and other heart disease symptoms.Cerebrovascular Disease: This affects blood flow to the brain, causing transient ischemic attacks (TIAs)...